Sign in
CompletedPhase 3

Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery

Key facts

Who runs it
University of Birmingham
Where
Brazil, India, Mexico, Nigeria, Rwanda, and South Africa38 sites in 6 countriesChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
11,668 people enrolled
Started
13 Nov 2020
Ended
30 Sept 2026
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Chlorhexidine mouthwash
  • Oxygen
Record updated
16 November 2026

Who can take part

Age
10 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Adults and children aged 10 years or over
  • Elective or emergency abdominal surgery via midline laparotomy with an anticipated abdominal incision of at least 5cm in length
  • Written informed consent of patient (signature or a fingerprint)

Who cannot take part

  • Previous enrolment in PENGUIN within the past 30 days
  • American Society of Anesthesiologists (ASA) grade V patients (expected to die with or without surgery)
  • Patients with a documented or suspected allergy to chlorhexidine
  • Patients undergoing caesarean section
  • Patient unable to complete postoperative follow-up (not contactable after discharge)

This trial has no sites in United States.

It has sites in 6 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

PENGUIN is a pragmatic multi-center trial investigating the effects of pre-operative mouthwash and perioperative oxygen on the incidences of pneumonia and surgical site infection (SSI) following major abdominal surgery.

Read full original descriptionShow less

Patients will be recruited from low and middle income countries and randomly assigned to a trial treatment arms: a) pre-operative chlorhexidine mouthwash and 80-100% FiO2; b) no pre-operative mouthwash and 80-100% fraction of inspired oxygen (FiO2); c) pre-operative chlorhexidine mouthwash and 21- 30% FiO2; or d) no pre-operative mouthwash and 21-30% FiO2.

The 4 groups in the trial

  • Mouthwash and liberal oxygen during surgeryTreatment being tested

    Pre-surgical mouthwash with 0.2% chlorhexidine gluconate in combination with 80-100% FiO2 during surgery.

    Treatment: Chlorhexidine mouthwash and Oxygen

  • No mouthwash and liberal oxygen during surgeryExisting treatment, for comparison

    No pre-surgical mouthwash in combination with 80-100% FiO2 during surgery.

    Treatment: Oxygen

  • Mouthwash and restrictive oxygen during surgeryTreatment being tested

    Pre-surgical mouthwash with 0.2% chlorhexidine gluconate in combination with 21-30% FiO2 during surgery.

    Treatment: Chlorhexidine mouthwash and Oxygen

  • No mouthwash and restrictive oxygen during surgeryExisting treatment, for comparison

    No pre-surgical mouthwash in combination with 21-30% FiO2 during surgery.

    Treatment: Oxygen

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
PErioperative Respiratory Care and Outcomes for patieNts Undergoing hIgh Risk abdomiNal Surgery: A 2x2 Factorial, International Pragmatic Randomised Controlled Trial Across Low and Middle-income Countries
Publications
Record updated
16 November 2026